NIH Course: NEW NIH & NHLBI POLICIES AND FUNDING OPPORTUNITIES FOR CLINICAL TRIALISTS (Thursday, 8:00AM-10:00AM)
NIH is the largest public funder of clinical trials in the United States with NHLBI being the primary Institute responsible for heart, lung, blood, and sleep-related research funding. Over the last couple of years, NIH has embarked in a comprehensive reform process with the overall goal of improvingthe quality and efficiency of the clinical trials it supports. NHLBI has been at the forefront of this effort, by developing new specific Funding Opportunity Announcement (FOA) for the different types of clinical trials it supports, from early phases to large multisite trials. The workshop will review the different types of FOAs available to clinical investigators and their specific requirements, with special focus on specific opportunities for new or early stage investigators.